Sanofi
Capitalisation boursière
$100.5B
Rang mondial
#164
Sommet historique
$109.9B
2024-12-31
Croissance totale
+0%
depuis 2026
Market Cap Context
- Larger than 55% of the 367 companies we track (globally).
- Equivalent to 3.0% of France's GDP (2025 data).
- Just above: #163 AXA SA ($100.6B)
- Just below: #165 Tata Consultancy Services (TCS) ($99.0B)
- Best year: 2012 (+32%). Worst year: 2002 (-30%).
Sanofi Financial Breakdown (FY 2025)
Source: Yahoo Finance — SAN.PA annual filings (2025) (converted from EUR at 0.93) →$50.2B revenue · $10.3B operating income · $8.4B net income
- ●Operating margin: 20.5% on $50.2B in revenue.
- ●R&D is 16.8% of revenue ($8.4B).
- ●Net income margin: 16.7% — $8.4B in profit.
- ●Free cash flow: $7.8B (15.4% of revenue).
Cost / Operating Expenses
Total operating expenses $39.9B
Total
$33.5B
Capital Expenditures
$3.8B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$7.8B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
À propos de Sanofi
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Historique de la capitalisation boursière de Sanofi (2026–2026)
Sanofi vs Sector Peers by Market Cap
Comparer Sanofi
Historique du classement
| Année | Capitalisation boursière | Rang | Variation sur un an |
|---|---|---|---|
| 2026 | $100.5B | #164(↓16) | -0.8% |
| 2025 | $101.3B | #148(↓25) | -7.9% |
| 2024 | $109.9B | #123(↓12) | +8.8% |
| 2023 | $101.1B | #111(↓14) | +3.6% |
| 2022 | $97.5B | #97(↑12) | +5.5% |
| 2021 | $92.4B | #109(↓1) | +16.9% |
| 2020 | $79.1B | #108(↓30) | -9.0% |
| 2019 | $86.8B | #78(↓8) | +23.4% |
| 2018 | $70.3B | #70(↑16) | +10.4% |
| 2017 | $63.7B | #86(↓29) | -3.5% |
| 2016 | $66.0B | #57(↓1) | +2.0% |
| 2015 | $64.7B | #56(↑3) | +7.2% |
| 2014 | $60.3B | #59(↓6) | +1.8% |
| 2013 | $59.3B | #53(↓12) | +11.6% |
| 2012 | $53.1B | #41(↑8) | +31.8% |
| 2011 | $40.3B | #49(↑16) | +24.1% |
| 2010 | $32.5B | #65(↓14) | -8.7% |
| 2009 | $35.6B | #51(↓5) | +27.9% |
| 2008 | $27.8B | #46(↑10) | -24.7% |
| 2007 | $36.9B | #56(↓15) | -7.6% |
| 2006 | $39.9B | #41(↓10) | -3.0% |
| 2005 | $41.2B | #31(↑3) | +28.5% |
| 2004 | $32.0B | #34 | +1.5% |
| 2003 | $31.6B | #34(↓6) | +4.1% |
| 2002 | $30.3B | #28(↓6) | -29.8% |
| 2001 | $43.2B | #22(↑18) | +18.8% |
| 2000 | $36.3B | #40 |
Autres entreprises du secteur Santé
FAQ
What is Sanofi's market cap?
Sanofi (SAN.PA) has a market capitalization of $100.5B, making it the #164 largest company in the world by market cap.
What was Sanofi's highest market cap?
Sanofi's all-time high market cap was $109.9B, reached in 2024-12-31. Its highest rank was #123 in 2024.
What sector is Sanofi in?
Sanofi is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in France.
How has Sanofi's market cap changed over time?
Sanofi has been tracked since 2026. Its market cap has grown by 0% from $100.5B in 2026 to $100.5B today.